317 related articles for article (PubMed ID: 32255561)
41. Demonstration of extracellular peptidylarginine deiminase (PAD) activity in synovial fluid of patients with rheumatoid arthritis using a novel assay for citrullination of fibrinogen.
Damgaard D; Senolt L; Nielsen MF; Pruijn GJ; Nielsen CH
Arthritis Res Ther; 2014 Dec; 16(6):498. PubMed ID: 25475141
[TBL] [Abstract][Full Text] [Related]
42. Autoantibodies against citrullinated histone H3 in rheumatoid arthritis and periodontitis patients.
Janssen KMJ; de Smit MJ; Withaar C; Brouwer E; van Winkelhoff AJ; Vissink A; Westra J
J Clin Periodontol; 2017 Jun; 44(6):577-584. PubMed ID: 28370244
[TBL] [Abstract][Full Text] [Related]
43. Peptidyl arginine deiminase immunization induces anticitrullinated protein antibodies in mice with particular MHC types.
Arnoux F; Mariot C; Peen E; Lambert NC; Balandraud N; Roudier J; Auger I
Proc Natl Acad Sci U S A; 2017 Nov; 114(47):E10169-E10177. PubMed ID: 29109281
[TBL] [Abstract][Full Text] [Related]
44. Autocitrullination and Changes in the Activity of Peptidylarginine Deiminase 3 Induced by High Ca
Sawata M; Shima H; Murayama K; Matsui T; Igarashi K; Funabashi K; Ite K; Kizawa K; Takahara H; Unno M
ACS Omega; 2022 Aug; 7(32):28378-28387. PubMed ID: 35990454
[TBL] [Abstract][Full Text] [Related]
45. Novel method to quantify peptidylarginine deiminase activity shows distinct citrullination patterns in rheumatoid and juvenile idiopathic arthritis.
Yu K; Dillemans L; Gouwy M; Bessa H; Metzemaekers M; Martens E; Matthys P; Bossuyt X; Verschueren P; Wouters C; De Somer L; Proost P
Front Immunol; 2023; 14():1111465. PubMed ID: 36793709
[TBL] [Abstract][Full Text] [Related]
46. Decreased severity of experimental autoimmune arthritis in peptidylarginine deiminase type 4 knockout mice.
Suzuki A; Kochi Y; Shoda H; Seri Y; Fujio K; Sawada T; Yamada R; Yamamoto K
BMC Musculoskelet Disord; 2016 May; 17():205. PubMed ID: 27150598
[TBL] [Abstract][Full Text] [Related]
47. Heightened immune response to autocitrullinated Porphyromonas gingivalis peptidylarginine deiminase: a potential mechanism for breaching immunologic tolerance in rheumatoid arthritis.
Quirke AM; Lugli EB; Wegner N; Hamilton BC; Charles P; Chowdhury M; Ytterberg AJ; Zubarev RA; Potempa J; Culshaw S; Guo Y; Fisher BA; Thiele G; Mikuls TR; Venables PJ
Ann Rheum Dis; 2014 Jan; 73(1):263-9. PubMed ID: 23463691
[TBL] [Abstract][Full Text] [Related]
48. Iguratimod inhibits protein citrullination and inflammation by downregulating NBCe2 in patients with rheumatoid arthritis.
Peng T; Li B; Bi L; Zhang F
Biomed Pharmacother; 2024 May; 174():116551. PubMed ID: 38636399
[TBL] [Abstract][Full Text] [Related]
49. Peptidylarginine deiminase 4 contributes to tumor necrosis factor α-induced inflammatory arthritis.
Shelef MA; Sokolove J; Lahey LJ; Wagner CA; Sackmann EK; Warner TF; Wang Y; Beebe DJ; Robinson WH; Huttenlocher A
Arthritis Rheumatol; 2014 Jun; 66(6):1482-91. PubMed ID: 24497204
[TBL] [Abstract][Full Text] [Related]
50. Insights into the study and origin of the citrullinome in rheumatoid arthritis.
Fert-Bober J; Darrah E; Andrade F
Immunol Rev; 2020 Mar; 294(1):133-147. PubMed ID: 31876028
[TBL] [Abstract][Full Text] [Related]
51. Brief report: citrullination within the atherosclerotic plaque: a potential target for the anti-citrullinated protein antibody response in rheumatoid arthritis.
Sokolove J; Brennan MJ; Sharpe O; Lahey LJ; Kao AH; Krishnan E; Edmundowicz D; Lepus CM; Wasko MC; Robinson WH
Arthritis Rheum; 2013 Jul; 65(7):1719-24. PubMed ID: 23553485
[TBL] [Abstract][Full Text] [Related]
52. Anti-PAD4 autoantibodies in rheumatoid arthritis: levels in serum over time and impact on PAD4 activity as measured with a small synthetic substrate.
Pollmann S; Stensland M; Halvorsen EH; Sollid LM; Kvien TK; Fleckenstein B; Molberg O
Rheumatol Int; 2012 May; 32(5):1271-6. PubMed ID: 21267570
[TBL] [Abstract][Full Text] [Related]
53. Peptidylarginine Deiminase 2 Gene Polymorphisms in Subjects with Periodontitis Predispose to Rheumatoid Arthritis.
Massarenti L; Enevold C; Damgaard D; Hansen PR; Frisch M; Ødum N; Jacobsen S; Nielsen CH
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076933
[TBL] [Abstract][Full Text] [Related]
54. Citrullination of fibrinogen by peptidylarginine deiminase 2 impairs fibrin clot structure.
Damiana T; Damgaard D; Sidelmann JJ; Nielsen CH; de Maat MPM; Münster AB; Palarasah Y
Clin Chim Acta; 2020 Feb; 501():6-11. PubMed ID: 31730822
[TBL] [Abstract][Full Text] [Related]
55. Peptidylarginine deiminase 4 (PAD4) activity in early rheumatoid arthritis.
Jonsson MK; Kantyka T; Falkowski K; Aliko A; Aga AB; Lillegraven S; Sexton J; Fevang BT; Mydel P; Haavardsholm EA
Scand J Rheumatol; 2020 Mar; 49(2):87-95. PubMed ID: 31544586
[No Abstract] [Full Text] [Related]
56. Association of anti-peptidyl arginine deiminase antibodies with radiographic severity of rheumatoid arthritis in African Americans.
Navarro-Millán I; Darrah E; Westfall AO; Mikuls TR; Reynolds RJ; Danila MI; Curtis JR; ; Rosen A; Bridges SL
Arthritis Res Ther; 2016 Oct; 18(1):241. PubMed ID: 27770831
[TBL] [Abstract][Full Text] [Related]
57. Antibodies to native and citrullinated RA33 (hnRNP A2/B1) challenge citrullination as the inciting principle underlying loss of tolerance in rheumatoid arthritis.
Konig MF; Giles JT; Nigrovic PA; Andrade F
Ann Rheum Dis; 2016 Nov; 75(11):2022-2028. PubMed ID: 26865600
[TBL] [Abstract][Full Text] [Related]
58. Subjects at-risk for future development of rheumatoid arthritis demonstrate a PAD4-and TLR-dependent enhanced histone H3 citrullination and proinflammatory cytokine production in CD14
Okamato Y; Ghosh T; Okamoto T; Schuyler RP; Seifert J; Charry LL; Visser A; Feser M; Fleischer C; Pedrick C; August J; Moss L; Bemis EA; Norris JM; Kuhn KA; Demoruelle MK; Deane KD; Ghosh D; Holers VM; Hsieh EWY
J Autoimmun; 2021 Feb; 117():102581. PubMed ID: 33310262
[TBL] [Abstract][Full Text] [Related]
59. Heightened autoantibody immune response to citrullinated calreticulin in bronchiectasis: Implications for rheumatoid arthritis.
Clarke A; Perry E; Kelly C; De Soyza A; Heesom K; Gold LI; Ollier W; Hutchinson D; Eggleton P
Int J Biochem Cell Biol; 2017 Aug; 89():199-206. PubMed ID: 28652209
[TBL] [Abstract][Full Text] [Related]
60. Platelets derived citrullinated proteins and microparticles are potential autoantibodies ACPA targets in RA patients.
Xu M; Du R; Xing W; Chen X; Wan J; Wang S; Xiong L; Nandakumar KS; Holmdahl R; Geng H
Front Immunol; 2023; 14():1084283. PubMed ID: 36761728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
